肿瘤的例句大全

The data were evaluated with a statistical analysis system ( windows 8 0 statistics package for social science) using χ 2 test and Logistic Regression.

使用Windows80版社会科学统计软件包对两组肿瘤的MR及临床观察指标进行单因素和多因素分析，统计学方法包括χ2检验和Logistic回归。

Serum p53 antibody appears to be a new tumor marker, and detecting of serum p53 antibody is expected to be a useful method of early diagnosis for colorectal cancer mass screening.

由于内窥镜检查费用高，程序复杂，而且属于有创伤性操作，不适合于临床筛检，因而血清p53抗体有可能作为一种新的肿瘤标志物对结直肠癌高危人群进行临床筛检，从而有助于早期诊断。

Results: The tumor volume and cell load were all differential significantly in each gade of WHO response. The relation between the WHO criteria and the LCK has been defined.

结果：每级别WHO疗效在相同或不同大小肿瘤都存在体积、细胞负荷和LCK的显著差异，WHO疗效评价与LCK相互换算关系得到确定。

Pancreatic cancer: Malignant tumour of the pancreas.

胰脏癌: 胰脏内的恶性肿瘤.

Progress of Mechanism Study on Malignant Tumor Treated by Principle of Yiqi Jianpi

益气健脾法治疗恶性肿瘤机理研究的进展

Conclusions: galectin-3 and VEGF-C can be good molecular markers in FNA diagnosis of thyroid lesions.

结论: Galectin -3 和VEGF -C 检测可以为甲状腺肿瘤细胞学诊断提供有价值的分子生物学依据.

Conclusion The uptake of 18 F-FLT in pulmonary malignant tissues is higher than that in normal tissues.

结论肺部恶性肿瘤组织中 18F-FLT 摄取高于正常组织.

Skp 2 is an Fbp, which targets many ubiquitin-mediated degradation of G 1-and S-phase regulators.

研究表明许多恶性肿瘤中存在着Skp2相关机制的异常, Skp2现已被认为是一种重要的癌基因.

The positive staining of VEGF in tumor cells and factor in new ECs was seen.

肿瘤细胞VEGF强阳性着色,新形成的血管内皮细胞因子抗体阳性.

Tumor stage was assigned by DRE results , according to the scientists.

肿瘤分期视DRE结果而评定.

DVH, DSH, TVR and tumor volume.

DVH, DSH, TVR,适形性及肿瘤控制情况.

DSA examination in 3 cases presented obvious staining of tumor.

行DSA检查3例,均显示明显的肿瘤染色.

The purified CTX-d without PLA 2 showed potent antitumor activity both in vivo and in vitro.

结果分离纯化获得的CTX-d 不混有PLA2,在体内外实验中显示明显的抗肿瘤作用.

These results further sulgest that CSB gene is a potential target for cancertheray.

本研究为深入研究CSB基因功能和开发其为抗肿瘤靶基因奠定了基础.

The objective of this study was to investigate the correlation of WHO criteria with the tumor volume, the tumor cell load and the LCK; and the necessity developing a method to measure LCK quantitatively.

本研究目的是探讨WHO疗效标准与肿瘤体积或细胞负荷及细胞对数杀灭（logcellkill，LCK或LK）相互关系及提出细胞对数杀灭定量评价方法的必要性。

Conclusion: WHO response criteria can not determine the tumor volume, the cell load as well as the LCK. A new method evaluating LCK quantitatively has been proposed and it may be interconverted with WHO response criteria.

结论：WHO标准不能定量评价肿瘤体积、细胞对数和LCK，提出可与WHO疗效评价相互换算的LCK定量评价方法非常必要。

Expression of cyclin D1 in parathyroid tumors and its clinical significance

甲状旁腺肿瘤中细胞周期素D1的表达及其临床意义

G1 arrest and apoptosis of mouse tumor after radiotherapy and electrochemical therapy

放疗结合电化疗对小鼠肿瘤组织细胞G1期阻断与凋亡的诱导

This paper reviews mechanisms of anti-tumors, the clinical outcomes and the pharmacokinetics of FK 228.

现综述FK228的 抗肿瘤 作用机制, 临床研究及药动学等方面的研究进展.

Cyclin D1 influences tumor classification and differentiation.

cyClin D1影响肿瘤组织类型和分化程度。